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ABSTRACT
Nutrition plays a fundamental role in determining the growth of individuals. An appropri-
ate growth progression is considered a harbinger of adequate nutrient intake and good
health. On the other hand growth deceleration with or without short stature may indicate
inadequate nutrition, even when there is no body weight deficit for height. Nutritional growth
retardation (NGR) is most prevalent in populations at risk of poverty. However in affluent com-
munities patients with NGR are often referred to the specialist because of short stature and
delayed sexual development. The diagnosis may be overlooked and/or be established after
exhaustive evaluations, if the pattern of weight progression over time is not considered.
Patients with so-called idiopathic short stature may present diminished nutrient intake and
decreased IGF-I levels, however their nutritional status and body weight progression patterns
are usually not addressed by pediatric endocrinologists. NGR patients may cease to gain
appropriate weight and fail to grow in height, even without exhibiting body weight deficits
for height. They adapt to decreased nutrient intake by decreasing growth progression and
thereby achieve equilibrium by decreasing the nutrient demands. This occurs by diminishing
their metabolic rates and erythrocyte Na+,K+- ATPase activity, however they may not present
alterations in other clinical biochemical markers of malnutrition. Therefore accurate weights
and heights plotted on the growth chart over time are necessary to detect NGR. Nutritional
rehabilitation is accompanied with catch up growth, though it may be difficult to change the
dietary habits of adolescents who exhibit NGR. 
Conflict of interest: None declared
Growth is the fundamental physiologic
process that characterizes childhood. It
should be closely monitored by pediatri-
cians and families alike as a benchmark of
a child’s health. Similarly, secular trends in
growth patterns are followed as indicators
of children’s health on a population level.
Growth can be worrisome along two vari-
ables: height (short stature) and velocity
(growth failure).
1 Height involves a meas-
urement of linear stature at a single point in
time and compares it to expected norms.
The norms are usually provided by the gen-
eral population as depicted in growth charts
(www.cdc.gov/growthcharts).
2 Short stature
and growth failure frequently, but not
always, occur together. For example, a
healthy child of short parents will have
short stature but not growth failure; he or
she will grow at normal velocity towards a
lower genetic potential. Conversely, a
child of very tall parents can have growth
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usefailure, but still be taller than the cut-off for
short stature of the general population. 
Multiple diseases can present solely with
growth failure, not necessarily with short
stature. Included are non-endocrine diseases
i.e. as celiac disease, cystic fibrosis, renal
disease and HIV infection.
1 These alterations
share a common pathophysiological process
in regards to growth failure, namely malnu-
trition. Non organic causes leading to
decreased food intake may also result in
poor growth and short stature. Failure to
asses a patients’ nutritional intake can lead
to unnecessarily delayed or missed NGR
diagnoses. The clinical outcome of many
nutritional alterations depends on the timeli-
ness of diagnosis and treatment.
3,4
The single most important cause of
growth retardation worldwide is poverty-
related malnutrition. When suboptimal nutri-
tion is continued for prolonged periods of
time, growth stunting occurs as the main
clinical phenotype.
3,4 However nutritional
growth retardation (NGR) is a frequently
under-appreciated entity in pediatric
endocrine practices in the United States.
Poverty-related malnutrition is less common
than in developing nations, and if anything,
the current major health crisis is the obesity
epidemic. Partly in response to the obesity
around them, a subset of American youths,
many from suburban upper middle class,
restrict their nutrient intake and develop
NGR and delayed sexual development.
1 This
decreased intake is on the continuum of
weight gain problems; it is insufficient to
support normal growth but it does not
include a distorted body image as occurs in
eating disorders.
5
Children with NGR are generally referred
to the pediatric endocrinologist because of
short stature or delayed puberty. Therefore,
pediatricians and pediatric endocrinologists
need to recognize NGR and become familiar
with its causes and treatment. Although the
importance of evaluating the pattern of
stature increments throughout life in the
differential diagnosis of short stature cannot
be over-emphasized, carefully assessing the
progression of body weight is equally rele-
vant to be able to recognize NGR.
Longitudinal assessment of both height and
weight is required.
6-9
An increasing number of children on
stimulant medications are being referred to
the pediatric endocrinologist for short stature
evaluation. Stimulant medication for the
treatment of attention deficit hyperactivity
disorder (ADHD) has long been suspected of
adversely affecting linear growth, since it is
well known that these medications produce
anorexia and poor nutrient intake. A cooper-
ative growth paper reviewed 29 cohort stud-
ies of children treated with methylphenidate
or dexamphetamine.
10 The most sensitive
studies measured growth progression before
and after the period of treatment, and eight
of these 16 studies showed an attenuation of
growth on stimulants. In the most rigorous
study, 540 children, 7-9 yr old, with ADHD
were randomly assigned to different treat-
ment groups for up to 24 months. The
behavioral effectiveness of medication use
was greatest among children who ingested
medications throughout the 24-month obser-
vation period. Those who stopped taking
their medication and those who did not
ingest them consistently showed increasing
behavioral problems. However, there was
significant growth deterioration among chil-
dren who took the medication for the
longest periods. After 2 years’ treatment,
height was suppressed by a mean of –1.94
cm and deficits in weight gain were even
larger. The authors concluded that consistent
treatment with stimulant medication was
associated with maintenance of behavioral
effectiveness but continued growth suppres-
sion.
11 The somewhat larger deterioration
observed in body weight may be due to the
anorexic effects of these medications.
Suboptimal nutrition appears to be an under-
lying cause of stimulant-mediated growth fal-
tering.
The classic anthropometric criteria for
NGR stipulate low weight for age with min-
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cross-sectional criteria, it may be difficult to
differentiate NGR children from those with
familial short stature or constitutional
growth delay.
6-9 Only the longitudinal pro-
gression of body weight and height can
more clearly reveal NGR, which may occur
even when there is weight-for-height
excess.
12 The distinguishing feature is a
delay in linear growth and puberty resulting
from inadequate weight gain. Thus,
although concern is intensified when weight
or height measurements fall below the 5th
percentile, growth failure expressed as dete-
rioration across percentiles of weight and
height may also indicate NGR even when
the child is still above the 5th percentile.
With nutritional rehabilitation, catch-up
growth is usually achieved.
1,7-9
Analysis of body weight progression may
be the most important clue for diagnosing
NGR in patients with short stature.
Calculation of theoretical weights and
heights based on previous growth per-
centiles may be used to quantitatively com-
pare current anthropometric indices with
previously established patterns of weight
and height progression.
1,7-9 Theoretical
weight is defined as the weight the patient
should have had at the time of the examina-
tion, if the patient had continued to gain
weight along the percentile previously
established during the pre-morbid growth
period. Body weight-for-height deficits are
not common in NGR, but the body weight is
often deficient relative to the theoretical
weight. In contrast, short patients without
NGR, such as those with constitutional
growth delay, continue to gain weight along
established percentiles and the body weight
at the time of assessment is equal to the the-
oretical body weight. A fall in growth asso-
ciated with a poor rate of weight gain indi-
cates NGR, even without an appreciable
weight-for-height deficit.
1,9,12
Patients with NGR do not appear wasted,
and the usual biochemical parameters of nu-
tritional status, including serum levels of
retinol-binding protein, pre-albumin, albu-
min, transferrin, and triiodothyronine (T3)
levels, do not differentiate NGR patients
from those with familial or constitutional
short stature. Other indices of malnutrition,
such as the urinary creatine-height index or
urinary nitrogen/creatinine ratio, do not usu-
ally demonstrate abnormalities. The reason
is that NGR patients have adapted to their
suboptimal nutritional intake and they main-
tain homeostasis by decreasing growth,
thereby reaching equilibrium with preserva-
tion of biochemical nutritional markers.
13
Although fasting and protein-calorie mal-
nutrition have been shown to lower circulat-
ing IGF-I levels in humans and rodents,
IGF-I levels may not differentiate NGR
patients from those with familial and/or con-
stitutional short stature. The degree of nutri-
tional insufficiency in NGR is not as severe
as that observed in protein-calorie mal-
nutrition or fasting, and may impair growth
by altering other cellular mechanisms with-
out affecting the serum IGF-I levels as dis-
cussed below. Because the energy restriction
is mild, and NGR children consume suffi-
cient dietary protein, IGF-I concentrations
may be preserved within a range appropri-
ate for bone age development. Likewise, rats
consuming diets containing 15% protein and
90% of the total energy requirements, main-
tained the IGF-I concentrations within nor-
mal ranges.
14
We reported that NGR patients show
decreased activity of erythrocyte Na+,K+-
ATPase compared with familial and/or con-
stitutional short stature patients.
13 This
enzyme is involved in the active transport of
sugars and amino acids and in cellular ther-
mogenesis, normally accounting for approx-
imately one-third of the basal energy
requirements. Reduced energy intake lowers
the basal metabolic rate and decreases Na+,
K+-ATPase activity. Because anthropometric
parameters may be lacking or inaccurate and
usual biochemical markers may not be suffi-
cient to detect NGR, a more sensitive test is
required for the diagnosis of NGR.
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offer such a diagnostic tool. However, to
date, this assay has not been widely avail-
able for clinical purposes, is cumbersome,
and has only been applied on a research
basis.
13,14
Growth deceleration is the adaptive
response to suboptimal nutrition, so patients
with NGR have achieved equilibrium
between their genetic growth potential and
their nutritional intake. Diminished growth
brings the nutrient demands into balance
with the nutritional intake, without adverse-
ly affecting biochemical or functional home-
ostatic measures. Of course, there are limits
to these adaptive possibilities. If nutritional
deprivation becomes more severe, or when
acute malnutrition is superimposed on the
chronic suboptimal state, there will be
altered anthropometric measurements, such
as weight and skin fold thickness, and bio-
chemical indices reflecting malnutrition.
The biochemical and hormonal changes
associated with chronic suboptimal nutrition
have been studied utilizing a rodent model.
Sodium-potassium ATPase activity was
reduced in rats fed less than 80% of ad-libi-
tum energy intake.
14 Body weight gain was
preserved in sub optimally fed rats treated
with recombinant human GH.
15,16
Furthermore, simultaneous restriction of
both energy and zinc did not augment the
growth deterioration of chronic suboptimal
nutrition.
17 Substitution of fat for carbohy-
drates led to greater body weight gains,
through reduced energy expenditure and
possibly decreased leptin secretion.
18 Other
changes due to chronic suboptimal nutrition
included a reduction of liver weight with an
increase in percent total polyunsaturates, n-
6 polyunsaturates and total unsaturates in
mitochondrial lipids. Suboptimal nutrition
also reduced mandibular and femur bone
growth. Finally, rats sub optimally fed for
three weeks showed decreased T-cell num-
bers in the thymus that may alter the
immune system. All these studies suggest
that minor biochemical and physiological
changes occur during chronic suboptimal
nutrition.
We have shown that diminished energy
intake resulting in NGR reduces metabolic
rate even before there is a loss of body
weight.
19 The rate of protein synthesis may
decrease in response to a reduction in en-
ergy intake, because this process is energy
expensive and accounts for 10–15% of the
basal metabolic rate.
20 It has long been
known that protein catabolism is also sensi-
tive to energy deprivation, such that reduced
dietary energy sources may lead to increased
nitrogen fiuxes in which protein breakdown
is accelerated to provide energy.
21,22 Nitrogen
retention markedly increases during nutri-
tional rehabilitation;
23 nutritional recovery
also normalizes the excretion of amino acids
and increases the rate of protein synthesis.
24
In NGR, the result of the altered rates of pro-
tein turnover and nitrogen retention may be
the cessation of normal growth, as an adap-
tive response to the decreased intake. In
addition to suboptimal energy intake, vari-
ous mineral and vitamin deficiencies have
been implicated in the etiology of NGR.
1,25
More recently we studied the changes in
the 24-hr metabolic and physical activity
profile of rodents undergoing chronic sub-
optimal nutrition to assess if the metabolic
adaptations contribute to the preservation of
body weight gain and growth.
26 We utilized
the rodent EMTAC to conduct accurate
measurements of continuous energy expen-
diture and physical activity in rats restricted
to 80, 70 or 60% of ad-libitum energy con-
sumed by controls. Rats that were restricted
to only 80% of their ad-libitum energy intake
grew at lower rates than those of the ad-libi-
tum fed controls. Furthermore, they pre-
served fat-free mass, but had reduced ener-
gy expenditure and physical activity, along
with increased respiratory quotients, during
the dark period at night. Thus, these rats uti-
lized their body fat and reduced their physi-
cal activity to conserve energy to preserve
lean body mass and to allow some growth.
However, rats fed only 70% of ad-libitum
Nutrition and Growth
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and lean body mass and had a greater mag-
nitude in the reduction of energy expendi-
ture and physical activity. Rats subjected to
even greater amounts of energy restriction,
such as those fed 60% of ad-libitum energy
intake, had even greater detrimental effects
such as reduced growth, loss of lean body
and fat mass along with further decreases in
energy expenditure and physical activity.
Despite consuming only 60% of their ad-libi-
tum energy intake, these rats still preserved
26% of their body weight gain as compared
to ad-libitum fed controls. This suggests that
over the course of the experiment, some
essential needs of metabolism were still
being met and a minimal amount of energy
was still available for growth.
26
Other physiological adaptations may
contribute to the maintenance of health and
body weight gain during chronic suboptimal
nutrition. For example, a reduction of body
temperature might be another mechanism
for energy conservation, since changes in
energy expenditure are directly related to
body temperature.
27 It is possible that other
factors might also contribute to the preserva-
tion of metabolic homeostasis, such as alter-
ations in erythrocyte sodium-potassium-
ATPase activity.
14 Nonetheless, it remains
controversial whether decreased body size is
an advantageous adaptation to a limited
food supply or whether adverse health and
functional impairments result. Mild energy
restriction in rodents has been repeatedly
shown to extend life span.
28
However it is difficult to conceive an
appropriate homeostasis that will allow opti-
mal health and prolongation of life with lev-
els of energy restriction that are associated
with poor growth and degradation of lean
body mass. Physical activity is decreased
with a 20% decrease in energy consumption,
and as mentioned above, energy expendi-
tures in rats promptly decrease with a rela-
tively mild energy restriction.
14,18,26 Moreover
there are other functional impairments that
are more difficult to assess, such as mental
capacity and learning ability that may also
be compromised. Decreased growth velocity
nevertheless constitutes a functional com-
promise per se, which should be detected
and treated as early as possible.
1,29-31
Nutritional rehabilitation for NGR of
nonorganic origin requires providing the
patient with adequate caloric and nutrient
intake for the restoration of previous growth
patterns. Initially, estimation of energy
requirements should be based on the age-
and gender-specific RDA based on the
patient’s theoretical weight. Adequate intake
of protein usually accompanies sufficient
caloric intake, but care should be taken that
micronutrient intakes meet the RDA and
specific deficiencies, such as iron or zinc,
should be treated.
30,31 Some patients may not
be willing or able to consume a completely
balanced diet and may require a multivita-
min and mineral supplement. A careful diet
history can elucidate food preferences and
eating patterns that need to be considered in
devising an appropriate dietary plan. Our
experience has been to offer general dietary
suggestions rather than to prescribe a specif-
ic diet. Frequent follow-up visits provide an
opportunity to revise and update dietary rec-
ommendations and to assess weight and
height improvements. Although the appro-
priate diet can be easily determined, suc-
cessful intervention requires a change in
dietary behaviors and possibly health beliefs
as well.
32 Increasing the caloric density of the
child’s diet often involves raising the dietary
fat and providing nutrient dense foods that
the patient and the family may not accept.
The assurance that an appropriate nutrition-
al intake will result in normal growth, with-
out producing obesity, is necessary support-
ive therapy. This is of particular concern in
the initial stages of the treatment, when
weight increases rapidly before any notice-
able effect on height is observed.
29-31
The USDA guidelines for dietary intake
were released, September 24 2004.
33 The DRIs
are evidence-based recommendations for
planning and assessing dietary intake of
Lifshitz F.
J Clin Res Ped Endo 2009;1(4):157–163 161apparently healthy people and the reader is
encouraged to refer to the DRI book or web-
site (http://www.nal.usda.gov/fnic/etext/
000105.html) when evaluating the dietary
intake of a given patient. However the USDA
food guide is a simpler guideline which
should serve the needs of Pediatric
Endocrinologists when evaluating the quality
of the dietary intake of a short child and to
provide guidelines for intake to the patients.
The consumption of the recommended foods
from each group is a fairly good indicator of
the adequacy of the dietary intake, if main-
tained over time.
33
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